Aug 6, 2012 | Digital Pathology, Instruments & Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Pathology
23andMe executives want the credibility that FDA clearance provides for its DNA tests and declared their intent to eventually support more clinical laboratory test applications Offering genetic tests directly to consumers is a controversial subject among some pathologists and healthcare ethics experts, who question both the science of these tests and whether consumers will do the right thing with the information. Now that debate is likely to heat up, because direct-to-consumer genetic testing...
Mar 18, 2011 | Digital Pathology, Laboratory News, Laboratory Pathology
Pathology departments may want to create similar courses to teach medical students how to interpret genetic and genotyping tests Genetic testing of participating university students was part of a special class that was conducted at the Stanford University School of Medicine last summer. The genetic pathology test was voluntary for the 54 students who participated in the eight-week course that was designed by a student. The genotyping happened as part of the class, titled “Genetics-210,...